
Lightpoint Medical raises £5m
Medical technology firm Lightpoint Medical has raised £5m from a group of investors.
Investors in the round included Cambridge Capital Group, Venture Founders, Coutts Investment Club, Envestors, Fund Twenty8, SyndicateRoom and Oxford Technology.
The funding will be used to commercialise its latest product, a robotic laparoscopic probe, and support the growth of existing products.
It also received a grant for £3m from EU-backed programme Horizon 2020 SME Instrument, and Innovate UK.
Company
Lightpoint was established in 2012 and is based in Chesham, near London. It produces technology that allows cancer to be detected in real time during surgery, with the aim of improving tissue sparing and clinical outcomes. The technology is based on administering patients a cancer-targeted imaging drug and then detecting it live during surgery.
People
Cambridge Capital Group – Stuart McDougall (managing director).
VentureFounders – James Codling (managing director).
Fund Twenty8 – James Sore (fund manager).
Lightpoint Medical – David Tuch (CEO).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater